期刊
JOURNAL OF CLINICAL INVESTIGATION
卷 121, 期 5, 页码 1871-1881出版社
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI44393
关键词
-
资金
- US NIH [T32-GM007464]
- Hellenic Cardiological Society
- American Heart Association
- H.A.
- Edna Benning Foundation
- Juvenile Diabetes Research Foundation
- Burroughs Wellcome Fund
Cerebral cavernous malformations (CCMs) are a common type of vascular malformation in the brain that are a major cause of hemorrhagic stroke. This condition has been independently linked to 3 separate genes: Krevl interaction trapped (KRIT1), Cerebral cavernous malformation 2 (CCM2), and Programmed cell death 10 (PDCD10). Despite the commonality in disease pathology caused by mutations in these 3 genes, we found that the loss of Pdcd10 results in significantly different developmental, cell biological, and signaling phenotypes from those seen in the absence of Ccm2 and Kritl. PDCD10 bound to germinal center kinase III (GCKIH) family members, a subset of serine-threonine kinases, and facilitated lumen formation by endothelial cells both in vivo and in vitro. These findings suggest that CCM may be a common tissue manifestation of distinct mechanistic pathways. Nevertheless, loss of heterozygosity (LOH) for either Pdcdl 0 or Ccm2 resulted in CCMs in mice. The murine phenotype induced by loss of either protein reproduced all of the key clinical features observed in human patients with CCM, as determined by direct comparison with genotype-specific human surgical specimens. These results suggest that CCM may be more effectively treated by directing therapies based on the underlying genetic mutation rather than treating the condition as a single clinical entity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据